🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Toripalimab

Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002) NCT04807140Phase 21 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: Toripalimab, nab-paclitaxel, carboplatin, Toripalimab, Surgical resection A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma NCT06843889Phase 21 site📍 Guangzhou Nanfang Hospital, Southern Medical University · Tests: Toripalimab (240mg day1, Q3W*3cycle) Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma NCT04778956Phase 37 sites📍 Guangzhou📍 Guangzhou📍 Guangzhou Sun Yat-sen University · Tests: Toripalimab, salvage surgery Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma NCT06721286Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Teripalimab, Gemcitabine + Cisplatin, Surgery Toripalimab Plus FLOT in Locally Advanced Gastric Cancer NCT04891016Phase 21 site📍 Zhengzhou Henan Cancer Hospital · Tests: FLOT combined with toripalimab Toripalimab Combined With Definitive CCRT for LACC Patients NCT06256224NA1 site📍 Shanghai Ruijin Hospital · Tests: Toripalimab, CCRT Standard Second-line Therapy With ONgericimab and TOripalimab in pMMR/MSS Colorectal Cancer: a Single-arm Phase II Trial NCT07106034Phase 21 site📍 Shanghai Shanghai Pudong Hospital · Tests: Ongericimab + Toripalimab + Bevacizumab + FOLFOX, Ongericimab + Toripalimab + Bevacizumab + FOLFIRI A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL) NCT04365036Phase 31 site📍 Guangzhou Sun Yat-sen University · Tests: Toripalimab, Pegaspargase, Gemcitabine, Oxaliplatin, Definitive intensity-modulated radiotherapy (IMRT) Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC NCT07177794Phase 31 site📍 Guangzhou Sun Yat-sen University · Tests: toripalimab, capecitabine Toripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal Cancer NCT06903858Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Toripalimab plus celecoxib, Non-operative management, Curative-intent surgery Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors NCT06088004Phase 1, Phase 25 sites📍 Beijing📍 Guangzhou📍 Nanning Suzhou Abogen Biosciences Co., Ltd. · Tests: ABO2011 Injection, Toripalimab EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC NCT07647289Phase 21 site📍 Beijing Peking University Third Hospital · Tests: enfortumab vedotin (EV), Toripalimab, Gemcitabine (Chemotherapy), Cisplatin Rimegepant Plus Toripalimab in Advanced Urothelial Carcinoma After Failure of Standard Therapy NCT07835035Phase 12 sites📍 Beijing📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Rimegepant, Toripalimab Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration NCT07307456Phase 21 site📍 Shanghai Changhai Hospital · Tests: Treatment with toripalimab combined with BCG perfusion following transurethral resection of bladder tumor (TURBT) LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC NCT07325539Phase 22 sites📍 Guangzhou📍 Shenzhen Sun Yat-sen University · Tests: Gemcitabine(GEM), Cisplatin, Toripalimab, LDRT Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence Factors NCT05768464Phase 22 sites📍 Nanjing📍 Nanning The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… · Tests: Toripalimab, Axitinib A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC. NCT06371274NA1 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: ATRA, Toripalimab Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH) NCT06437977Phase 31 site📍 Shanghai Shanghai Chest Hospital · Tests: SBRT, Toripalimab Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors NCT05579275EARLY Phase 11 site📍 Beijing Peking University Cancer Hospital & Institute · Tests: JCXH-212 Injection Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive Expression NCT06269211Phase 22 sites📍 Guangzhou📍 Shanghai Ruijin Hospital · Tests: Toripalimab Efficacy and Safety Study of Disitamab Vedotin + RC148 vs. Albumin-Paclitaxone ± Toripalimab in HR-/HER2-low Breast Cancer NCT06642545Phase 21 site📍 Beijing RemeGen Co., Ltd. · Tests: Disitamab Vedotin, RC148, Albumin-bound Paclitaxone, Toripalimab Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02) NCT06682195Phase 213 sites📍 Nanchang📍 Hangzhou📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: Neoadjuvant chemotherapy combined with Toripalimab A Study of RC48-ADC Combined With JS001 for Advanced Extramammary Paget Disease of the Scrotum NCT06791070Phase 21 site📍 Fuzhou Fujian Medical University Union Hospital · Tests: Disitamab Vedotin combined with Toripalimab 9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma NCT06823427Phase 22 sites📍 Changsha📍 Nanjing Mabwell (Shanghai) Bioscience Co., Ltd. · Tests: 9MW2821, Toripalimab (JS001 ) ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC NCT06426511Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Toripalimab+Chemotherapy, Toripalimab+Chemotherapy followed by consolidation toripalimab A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours NCT06868199Phase 1, Phase 26 sites📍 Ryde📍 Ryde📍 Wollongong LaNova Medicines Limited · Tests: LM-168, Toripalimab PDT For Induction Therapy For Head And Neck Cancer NCT07214987Phase 22 sites📍 Boston📍 Boston Massachusetts General Hospital · Tests: Toripalimab-tpzi, Cisplatin, Docetaxel A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors. NCT07392736Phase 1, Phase 215 sites📍 Beijing📍 Beijing📍 Hunan Advenchen Laboratories, LLC · Tests: AL8326 tablets, Toripalimab Multicenter, Single-Arm, Prospective Phase II Study of Neoadjuvant Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy for Resectable Stage IB-IIIB Non-Small Cell Lung Cancer NCT07855965Phase 29 sites📍 Chengdu📍 Chengdu📍 Chengdu West China Hospital · Tests: Cryo-Thermal Ablation, Toripalimab, Platinum-based doublet chemotherapy Toripalimab Plus Cetuximab and Irinotecan for Second-Line Right-Sided RAS/BRAF Wild-Type Advanced Colon Cancer Phase II Study NCT07896681Phase 21 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Toripalimab, Cetuximab, Irinotecan
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy